Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors

Phase II trial shows pasireotide offers symptom relief

2012-08-06

(Press-News.org) A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG. The Phase II, open-label, multicenter study in patients with advanced neuroendocrine tumors (NET) whose symptoms were no longer responsive to octreotide LAR therapy found that the drug was effective and well tolerated in controlling patient symptoms.

The study results are reported in a recent issue of Endocrine-Related Cancer, a publication of the Society for Endocrinology.

"Neuroendocrine tumors are often asymptomatic and, by the time of diagnosis, have frequently metastasized, usually to the liver," said the study's corresponding author, Larry K. Kvols, M.D., a senior member at Moffitt and section head of neuroendocrine oncology. "Surgery is essential in managing metastatic NET and can be curative for early disease, but the majority of patients need further treatment."

According to Kvols, octreotide and lanreotide, drugs that mimic natural somatostatin, have been "the mainstay" for symptom management of neuroendocrine tumors. However, many patients eventually fail to respond to this treatment and have poor prognoses.

"Pasireotide is a novel multireceptor-targeted somatostatin analogue that binds to four of the five known somatostatin receptor subtypes," said Kvols, whose research is in experimental therapies for neuroendocrine cancer. "Because of its binding ability, it may offer symptom reduction for patients who have eventually failed to respond to traditional therapy."

The multicenter clinical trial, conducted at sites in the United States and Europe, enrolled 89 patients and evaluated 44 for efficacy and 45 for tolerability. Pasireotide "effectively controlled symptoms." Evaluation of tumor response in 23 patients showed 13 with stable disease and 10 with progressive disease. The drug was "effective and well-tolerated" and adverse events, most commonly gastrointestinal, were "mild or moderately severe."

The study was funded in part through funding by Novaratis Pharmaceuticals.

A Phase III study evaluating pasireotide versus octreotide is ongoing for patients with advanced NET whose disease-related symptoms have been inadequately controlled.

###About Moffitt Cancer Center Follow Moffitt on Facebook: www.facebook.com/MoffittCancerCenter Follow Moffitt on Twitter: @MoffittNews Follow Moffitt on YouTube: MoffittNews

Located in Tampa, Moffitt Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center, which recognizes Moffitt's excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt is also a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer.

Media release by Florida Science Communications

ELSE PRESS RELEASES FROM THIS DATE:

Increased productivity, not less energy use, results from more efficient lighting

2012-08-06

ALBUQUERQUE, N.M. — Two researchers have reprised in the journal Energy Policy their groundbreaking finding that improvements in lighting — from candles to gas lamps to electric bulbs — historically have led to increased light consumption rather than lower overall energy use by society. In an article in the journal Energy Policy, Sandia researcher Jeff Tsao and Harry Saunders of The Breakthrough Institute in Oakland, Calif., predicted in 2010 that the same phenomenon might apply to light-emitting diodes (LEDs), poised to take over from the Edison light bulb as the ...

White blood cells mediate insulin resistance

2012-08-06

Researchers at the University of California, San Diego School of Medicine say neutrophils, an abundant type of white blood cell typically tasked with attacking bacteria and other foreign invaders, also plays an unexpected role in mediating insulin resistance – the central characteristic of type 2 diabetes, which afflicts an estimated 26 million Americans. The findings are published in the August 5, 2012 Advance Online Publication of Nature Medicine. Neutrophils are the first immune cells to respond to tissue inflammation, and can promote chronic inflammation by summoning ...

New study finds link between cell division and growth rate

2012-08-06

CAMBRIDGE, Mass. -- It's a longstanding question in biology: How do cells know when to progress through the cell cycle? In simple organisms such as yeast, cells divide once they reach a specific size. However, determining if this holds true for mammalian cells has been difficult, in part because there has been no good way to measure mammalian cell growth over time. Now, a team of MIT and Harvard Medical School (HMS) researchers has precisely measured the growth rates of single cells, allowing them to answer that fundamental question. In the Aug. 5 online edition of ...

Sequencing of malaria genomes reveals challenges, opportunities in battle against parasite

2012-08-06

Genetic variability revealed in malaria genomes newly sequenced by two multi-national research teams points to new challenges in efforts to eradicate the parasite, but also offers a clearer and more detailed picture of its genetic composition, providing an initial roadmap in the development of pharmaceuticals and vaccines to combat malaria. The research appears in two studies published in the latest issue of the journal Nature Genetics. They focus on Plasmodium vivax (P. vivax), a species of malaria that afflicts humans and the most prevalent human malaria parasite outside ...

Researchers discover new mechanism behind resistance to cancer treatment

2012-08-06

SEATTLE – Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence for cancer patients with solid tumors – such as those of the breast, prostate, lung and colon – that have metastasized, or spread, throughout the body. A team of scientists led by Fred Hutchinson Cancer Research Center has discovered a key factor that drives this drug resistance – information that ultimately may be used to improve the effectiveness of therapy and buy precious time for patients with advanced cancer. They describe their findings online Aug. 5 in advance of ...

Out of Europe

2012-08-06

Researchers have found that a bacterium that emerged centuries ago in Europe has now been spreading globally into countries undergoing rapid development and industrialization. Unlike other diarrheal diseases, this one is unlikely to be resolved by providing access to clean water. As developing countries become more industrialized the numbers of infections with dysentery-causing Shigella flexneri are known to decline, associated with improved health, lifestyle and perhaps most importantly access to clean water, but the incidence of another form of the dysentery-causing bacterium, ...

New study helps predict impact of ocean acidification on shellfish

2012-08-06

An international study to understand and predict the likely impact of ocean acidification on shellfish and other marine organisms living in seas from the tropics to the poles is published this week (date) in the journal Global Change Biology. Ocean acidification is occurring because some of the increased carbon dioxide humans are adding to the atmosphere dissolves in the ocean and reacts with water to produce an acid. The results suggest that increased acidity is affecting the size and weight of shells and skeletons, and the trend is widespread across marine species. ...

Heart muscle cell grafts suppress arrhythmias after heart attacks in animal study

2012-08-06

VIDEO: Stem-cell derived heart muscle cells were genetically labeled with fluorescent calcium to flash when they contract. By correlating this optical signal from the graft cells with an electrocardiogram --... Click here for more information. Researchers have made a major advance in efforts to regenerate damaged hearts. Grafts of human cardiac muscle cells, grown from embryonic stem cells, coupled electrically and contracted synchronously with host muscle following transplantation ...

New technology eliminates plant toxins

2012-08-06

Plants produce toxins to defend themselves against potential enemies, from herbivorous pests to diseases. Oilseed rape plants produce glucosinolates to serve this purpose. However, due to the content of glucosinolates, farmers can only use limited quantities of the protein-rich rapeseed for pig and chicken feed. Now, a team of researchers from the University of Copenhagen has developed a method to hinder unwanted toxins from entering the edible parts of the plant. The breakthrough was published today in the prominent scientific journal Nature. "We have developed an entirely ...

Leaky water pipes problem solved by Sheffield engineers

2012-08-06

Leaky pipes are a common problem for the water industry: according to UK regulator, Ofwat, between 20 and 40 per cent of the UK's total water supply can be lost through damaged pipes. Developing more accurate ways of finding leaks would enable water companies to save revenue and reduce their environmental impact. The system invented at Sheffield tests pipes by transmitting a pressure wave along them that sends back a signal if it passes any unexpected features, such as a leak or a crack in the pipe's surface. The pressure wave is generated by a valve fitted to an ordinary ...

Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: